GlassScriptPhysician profile
Afrouz Gerayli
NPI 1801044839
$9,064.03
in general payments reported to CMS, 2019-2025
39 companies · $1,685 in 2025
The $1,685 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $894 · 2020: $748 · 2021: $1,537 · 2022: $1,475 · 2023: $1,214 · 2024: $1,511 · 2025: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,409.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,630.44 | 2019-2025 | Evenity, Repatha, Prolia |
| Astrazeneca Pharmaceuticals LP | $1,195.56 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $975.77 | 2019-2025 | |
| Lilly USA, LLC | $580.00 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $545.56 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Abbott Laboratories | $482.66 | 2021-2025 | Aveir, Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $403.92 | 2019-2025 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $266.81 | 2019-2023 | |
| Boston Scientific Corporation | $262.94 | 2025 | Watchman Flx, Farapulse |
| Pfizer INC. | $259.49 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $247.93 | 2019-2025 | |
| Nestle Healthcare Nutrition INC. | $224.14 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $212.25 | 2019-2022 | |
| Glaxosmithkline, LLC. | $161.42 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Nevro Corp. | $161.36 | 2024 | Senza |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Afrouz Gerayli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.